Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (19)

2023

  1. Fluctuation of Anti–Domain 1 and Anti–β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

    Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 984-995

2021

  1. Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century-an observational study from the Lupus-Cruces cohort

    Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 249-257

  2. Clinical presentation of antiphospholipid syndrome

    Lahita’s Systemic Lupus Erythematosus (Elsevier), pp. 561-574

2020

  1. Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care data

    PLoS ONE, Vol. 15, Núm. 9 September

2018

  1. Combined mepacrine–hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity

    Lupus, Vol. 27, Núm. 10, pp. 1718-1722

  2. Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study

    Psychiatry Research, Vol. 268, pp. 1-7

2017

  1. A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

    Journal of Clinical Psychopharmacology, Vol. 37, Núm. 5, pp. 569-577

  2. Psychoeducational preventive treatment for women at risk of postpartum depression: Study protocol for a randomized controlled trial, PROGEA

    BMC Psychiatry, Vol. 17, Núm. 1

  3. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2016

  1. Opposite cannabis-cognition associations in psychotic patients depending on family history

    PLoS ONE, Vol. 11, Núm. 8

  2. Psychometric properties and validation of a four-item version of the Strauss–Carpenter scale in bipolar disorder

    International Journal of Bipolar Disorders, Vol. 4, Núm. 1

2014

  1. Novel association of Neuregulin 1 gene with bipolar disorder but not with schizophrenia

    Schizophrenia Research

  2. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone

    Lupus, Vol. 23, Núm. 3, pp. 323-326

  3. Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder

    Journal of Affective Disorders, Vol. 160, pp. 50-54

2012

  1. One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder

    Acta Psychiatrica Scandinavica, Vol. 125, Núm. 4, pp. 335-341

2011

  1. Can positive family factors be protective against the development of psychosis?

    Psychiatry Research, Vol. 186, Núm. 1, pp. 28-33

2010

  1. Manic and depressive symptoms and insight in first episode psychosis

    Psychiatry Research, Vol. 178, Núm. 3, pp. 480-486

2007

  1. Antimalarials may influence the risk of malignancy in systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 6, pp. 815-817

  2. Restless legs syndrome in Parkinson's disease

    Movement Disorders, Vol. 22, Núm. 13, pp. 1912-1916